Kymera Therapeutics
KYMR
KYMR
126 hedge funds and large institutions have $1.15B invested in Kymera Therapeutics in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more capital invested
Capital invested by funds: $972M → $1.15B (+$178M)
0.98% more ownership
Funds ownership: 95.55% → 96.53% (+0.98%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
126
Holding in Top 10
3
Calls
$2.67M
Puts
$1.99M
Top Buyers
| 1 | +$19.8M | |
| 2 | +$17.3M | |
| 3 | +$12.1M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$10.9M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$10.7M |
Top Sellers
| 1 | -$35.4M | |
| 2 | -$24.5M | |
| 3 | -$18M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$3.57M |
| 5 |
Morgan Stanley
New York
|
-$3.51M |